The Scheme does not guarantee / indicate any returns. The UTI Gilt Fund with 10 year Constant Duration Direct Growth has an AUM of 166.88 crores & has delivered CAGR of 0.00% in the last 5 years.
The Scheme does not guarantee / indicate any returns. The UTI Gilt Fund with 10 year Constant Duration Regular Growth has an AUM of 166.88 crores & has delivered CAGR of 0.00% in the last 5 years.
1. Current NAV: The Current Net Asset Value of the UTI Nifty 10 yr Benchmark G-Sec ETF as of Nov 18, 2024 is Rs 24.23 for Growth option of its Regular plan. 2. Returns: Its trailing returns over ...
1. Current NAV: The Current Net Asset Value of the UTI Gilt Fund with 10 year Constant Duration - Direct Plan as of Nov 19, 2024 is Rs 12.03 for Growth option of its Direct plan. 2. Returns: Its ...
One of the frustrating things about a urinary tract infection (UTI) is that it interferes with sex. It is one thing when it happens every once in a while; it's another when it becomes an ongoing, ...
You can get a urinary tract infection (UTI) by being sexually active, holding your pee, or wiping from front to back. A UTI is an infection of the bladder, kidneys, ureters, or urethra. The main ...
Peter Weiss, MD, is a practicing OB/GYN and former Assistant Clinical Professor at the UCLA School of Medicine. The difference between urinary tract infection (UTI) and pregnancy symptoms include ...
Involves transaction of at least 0.5% of the listed shares of a company. UTI Nifty 10 yr Benchmark G-Sec ETF share price was down by 0.00% from the previous closing price of ₹24.15. Who are ...
The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...